Long-term effects of central leptin and resistin on body weight, insulin resistance, and beta-cell function and mass by the modulation of hypothalamic leptin and insulin signaling.
To determine the long-term effect of central leptin and resistin on energy homeostasis, peripheral insulin resistance, and beta-cell function and mass, intracerebroventricular (ICV) infusion of leptin (3 ng/h), resistin (80 ng/h), leptin plus resistin, and cerebrospinal fluid (control) was conducted by means of an osmotic pump for 4 wk on normal rats and 90% pancreatectomized diabetic rats fed 40% fat-energy diets. Overall, the effects were greater in diabetic rats than normal rats. Leptin infusion, causing a significant reduction in food intake, decreased body weight and epididymal fat. However, resistin and leptin plus resistin reduced epididymal fat with decreased serum leptin levels in comparison with the control. Unlike serum leptin, only resistin infusion lowered serum resistin levels. Central leptin increased glucose infusion rates during euglycemic hyperinsulinemic clamp and suppressed hepatic glucose production in the hyperinsulinemic state in comparison with the control. However, central leptin did not affect glucose-stimulated insulin secretion and beta-cell mass. Central resistin infusion also increased peripheral insulin sensitivity, but not as much as leptin. Unlike leptin, resistin significantly increased first-phase insulin secretion during hyperglycemic clamp and beta-cell mass by augmenting beta-cell proliferation. These metabolic changes were associated with hypothalamic leptin and insulin signaling. ICV infusion of leptin potentiated signal transducer and activator of transcription 3 phosphorylation and attenuated AMP kinase in the hypothalamus, but resistin had less potent effects than leptin. Leptin enhanced insulin signaling by potentiating IRS2-->Akt pathways, whereas resistin activated Akt without augmenting insulin receptor substrate 2 phosphorylation. In conclusion, long-term ICV infusion of leptin and resistin independently improved energy and glucose homeostasis by modulating in different ways hypothalamic leptin and insulin signaling.
Park
Sunmin
S
Department of Food and Nutrition, Hoseo University, Asan-Si, Chungnam-Do, Korea. smpark@hoseo.edu
Hong
Sang Mee
SM
Sung
So Ra
SR
Jung
Hye Kyung
HK
D000818:Animals; D017209:Apoptosis / Q000502:physiology; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight / Q000187:drug effects; D002455:Cell Division / Q000502:physiology; D004435:Eating / Q000187:drug effects / Q000502:physiology; D015309:Glucose Clamp Technique; D005951:Glucose Tolerance Test; D006946:Hyperinsulinism / Q000378:metabolism; D007031:Hypothalamus / Q000378:metabolism*; D007276:Injections, Intraventricular; D007328:Insulin / Q000097:blood / Q000378:metabolism; D007333:Insulin Resistance / Q000502:physiology*; D000078790:Insulin Secretion; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D050417:Insulin-Secreting Cells / Q000166:cytology / Q000378:metabolism / Q000502:physiology*; D020738:Leptin / Q000097:blood* / Q000494:pharmacology; D008297:Male; D010180:Pancreatectomy; D051381:Rats; D017207:Rats, Sprague-Dawley; D052243:Resistin / Q000097:blood* / Q000494:pharmacology; D015398:Signal Transduction / Q000502:physiology
D001786:Blood Glucose; D007328:Insulin; D020738:Leptin; D052243:Resistin; C499622:Retn protein, rat; D007334:Insulin-Like Growth Factor I